OMB
.report
Search
Outsourcing Facilities: Registration and reporting of drugs under 503B(b)
Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
21 USC 353b Sec 503B FFDCA OCT 2022
Outsourcing Facilities: Registration and reporting of drugs under 503B(b)
OMB: 0910-0800
OMB.report
HHS/FDA
OMB 0910-0800
ICR 202512-0910-009
IC 256583
Outsourcing Facilities: Registration and reporting of drugs under 503B(b)
( )
Document [pdf]
Download:
pdf
|
pdf
File Type
application/pdf
File Title
about_blank
Author
DHC
File Modified
2022-10-25
File Created
2022-10-25
© 2026 OMB.report |
Privacy Policy